Skip to main content
. 2020 Oct 21;2020(10):CD013750. doi: 10.1002/14651858.CD013750

3.2. Analysis.

3.2

Comparison 3: Platinum vs non‐platinum regimens (subgroup analysis 2: by type of platinum agent in platinum arm), Outcome 2: Progression‐free survival/time to progression